Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme.

AIDS. 1995 Sep;9(9):1067-70. Unique Identifier : AIDSLINE MED/96085723
Peak A; Rana S; Maharjan SH; Jolley D; Crofts N; Lifesaving and Lifegiving Society, Kathmandu, Nepal.

Abstract: OBJECTIVE: To measure changes in self-reported risk behaviour for HIV infections and HIV seroprevalence among injecting drug user (IDU) clients of an outreach harm-reduction programme in Kathmandu, Nepal. METHODS: The Lifesaving and Lifegiving Society (LALS) of Kathmandu began providing sterile injecting equipment and education to Nepalese IDU in 1991. A sample of these IDU were interviewed and tested for HIV each year from 1991 through 1994. RESULTS: Indicators of unsafe injecting fell, as knowledge of HIV rose more in 1994 for those who had been in touch with LALS for longer. Indicators of unsafe sex did not change. HIV seroprevalence remained low, 1.6% in 1991 and 0% in 1994. CONCLUSION: We conclude that programmes for the prevention of HIV spread among IDU are possible and effective in Asia, and are urgently needed.
Keywords: Adult *Developing Countries Female Health Education/*TRENDS Human HIV Infections/*PREVENTION & CONTROL/TRANSMISSION HIV Seroprevalence/*TRENDS Knowledge, Attitudes, Practice Male Needle-Exchange Programs/*TRENDS Nepal/EPIDEMIOLOGY Risk Factors Sex Behavior Substance Abuse, Intravenous/*EPIDEMIOLOGY Support, Non-U.S. Gov't JOURNAL ARTICLEKWDadultKWDdevelopingcountriesfemalehealtheducation/KWDtrendshumanhivinfections/KWDprevention&control/transmissionhivseroprevalence/KWDtrendsknowledge,attitudes,practicemaleneedle-exchangeprograms/KWDtrendsnepal/epidemiologyriskfactorssexbehaviorsubstanceabuse,intravenous/KWDepidemiologysupport,non-uKWDsKWDgov'tjournalarticle
960430
M9640865

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .